Home Cart 0 Sign in  

[ CAS No. 7533-40-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 7533-40-6
Chemical Structure| 7533-40-6
Structure of 7533-40-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 7533-40-6 ]

Related Doc. of [ 7533-40-6 ]

Alternatived Products of [ 7533-40-6 ]

Product Details of [ 7533-40-6 ]

CAS No. :7533-40-6 MDL No. :MFCD00063676
Formula : C6H15NO Boiling Point : -
Linear Structure Formula :- InChI Key :VPSSPAXIFBTOHY-LURJTMIESA-N
M.W : 117.19 Pubchem ID :111307
Synonyms :
(+)-Leucinol

Calculated chemistry of [ 7533-40-6 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 34.83
TPSA : 46.25 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.76 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.77
Log Po/w (XLOGP3) : 0.36
Log Po/w (WLOGP) : 0.35
Log Po/w (MLOGP) : 0.61
Log Po/w (SILICOS-IT) : 0.2
Consensus Log Po/w : 0.66

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.6
Solubility : 29.8 mg/ml ; 0.254 mol/l
Class : Very soluble
Log S (Ali) : -0.9
Solubility : 14.9 mg/ml ; 0.127 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.57
Solubility : 31.3 mg/ml ; 0.267 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.21

Safety of [ 7533-40-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 7533-40-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 7533-40-6 ]
  • Downstream synthetic route of [ 7533-40-6 ]

[ 7533-40-6 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 2666-93-5 ]
  • [ 7533-40-6 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1981, p. 231 - 235
[2] Agricultural and Biological Chemistry, 1983, vol. 47, # 4, p. 829 - 838
[3] Journal of Chemical Research, 2009, # 11, p. 665 - 667
[4] Bulletin des Societes Chimiques Belges, 1991, vol. 100, # 1, p. 63 - 77
[5] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1973, p. 2094 - 2097
[6] Bulletin des Societes Chimiques Belges, 1985, vol. 94, # 8, p. 605 - 614
[7] Advanced Synthesis and Catalysis, 2001, vol. 343, # 8, p. 802 - 808
[8] Patent: US6353006, 2002, B1, . Location in patent: Page column 176
  • 2
  • [ 7517-19-3 ]
  • [ 7533-40-6 ]
YieldReaction ConditionsOperation in experiment
65% With sodium tetrahydroborate; sodium hydrogencarbonate In ethanol; water at 15℃; Heating / reflux To a mixture of (L)-leucine methyl ester HCl salt (254 g, 1.4 mol), NaHCO3, (118 g, 1.4 mol, 1.0 equiv.) and water (1.8 L) in EtOH (1.8 L) at 5° C. was added NaBH4, (159 g, 4.2 mol, 3.0 equiv.) in portions at such a rate that the reaction temp. did not exceed 15° C. (approximately 70 min). After the addition of NaBH4 was complete, the ice bath was removed and the reaction was heated to the reflux temp. overnight. The resulting mixture was cooled to room temp. with the aid of an ice bath. The resulting slurry was filtered and the solids were washed with EtOH (750 mL). The combined filtrates were concentrated to approximately 950 mL under reduced pressure. The residue was diluted with EtOAc (2.5 L) and extracted with a 1N NaOH solution (2.x.1 L). The aqueous layer was back-extracted with EtOAc (2.x.750 mL). The combined organics were dried (MgSO4) and concentrated under reduced pressure to yield (1S)-1-(hydroxymethyl)-3-methylbutylamine as a pale yellow oil (112 g, 65percent): 1H NMR (CDCl3) δ0.88-0.93 (m, 6H), 1.17 (t, J=7.7 Hz, 2H), 1.68-1.80 (m, 2H), 1.82 (br s, 2H), 2.86-2.91 (m, 1H), 3.22 (dd, J=10.7, 8.1 Hz 1H), 3.56, (dd, J=10.3, 3.6 Hz, 1H)
Reference: [1] Patent: US6353006, 2002, B1, . Location in patent: Page column 31
  • 3
  • [ 61-90-5 ]
  • [ 7533-40-6 ]
YieldReaction ConditionsOperation in experiment
82%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 5℃; for 16.75 h; Heating / reflux
Stage #2: With water In tetrahydrofuran; diethyl ether
Example 3 Synthesis of Compound 3 Hydrochloride salt; a. Synthesis of intermediate B; To a solution of dry THF (250 ml) was slowly charged lithium aluminum hydride (10.84 g, 0.151 mol) at 0 C over 30 minutes. To this reaction mixture was charged, in portions, L-leucine (25.Og, 0.227 mol) over a period of 45 minutes while maintaining the reaction mixture temperature between 0-5 C to control the vigorous evolution of hydrogen. The resulting reaction mixture was then heated to reflux and maintained at reflux for 16 hours at which time it was cooled to 0-5 C, diluted with diethyl ether (300 ml) and slowly quenched with DI water (12 ml). To the quenched solution was charged 15percent w/v NaOH solution (12 ml) which resulted in the precipitation of a white solid. The slurry was stirred at room temperature for 30 minutes and the white solid was removed by filtration to give a clear organic filtrate which was dried with sodium sulfate (q.s.). The sodium sulfate was removed by filtration and the organic solution was concentrated under reduced pressure to afford intermediate B as a yellow liquid (20 g, 90percent).
59.5%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 24.5 h; Heating / reflux
Stage #2: With sodium hydroxide; water In tetrahydrofuran for 0.5 h;
L-Leucinol (LeuOH). Ten grams of L-Leucine (76.2 mmol) was suspended in 100 mL of THF under the nitrogen atmosphere. The suspension was cooled in the ice bath and 4 g of lithium aluminum hydride (100 mmol) was added over a 30 min period. After the addition was complete, the ice bath was removed and the reactant was warmed to room temperature and then refluxed for 24 hours under nitrogen. The reactant was quenched with water (4 mL), then aqueous 15percent of sodium hydroxide (4 mL), and water 12 mL. The solution was stirred for 30 min and white precipitate is filtrated. The filter cake was washed with Dichloromethane and the combined organic layer was dried with sodium sulfate, and concentrated under reduced pressure (8.7 g., 97 percent). The L-leucinol was isolated by distillation. Bp 90 0C (0.9 mm) lit. 64-65 0C (1.5 mm) Yield 5.3 g (59.5 percent) colorless liquid was obtained. 98percent (GC). 1H NMR: δ 3.56 and 3.23 (d-d and t, 2H, CH2-OH); 3.29 (m, IH, H2N-C*H) 1.8-2.4 (br, 3η, NH2 and OH) 1.68 (m, 1η, Cη2-CH(Cη3)2); 1.21 (t, 2H, C*H- CH2-CH); 0.89-0.94 (m, 6H, CH(CH3)2). 13C NMR: δ 67.12, 50.83, 43.68, 24.89, 23.58, 22.38.
Reference: [1] Chemical Communications, 1997, # 12, p. 1087 - 1088
[2] Synthetic Communications, 1996, vol. 26, # 4, p. 703 - 706
[3] Chemical Communications, 2014, vol. 50, # 50, p. 6656 - 6659
[4] Molecules, 2011, vol. 16, # 9, p. 7551 - 7564
[5] Journal of Organic Chemistry, 2010, vol. 75, # 3, p. 772 - 782
[6] Synthetic Communications, 2012, vol. 42, # 19, p. 2907 - 2916
[7] Russian Chemical Bulletin, 2008, vol. 57, # 9, p. 1981 - 1988
[8] Patent: WO2008/11539, 2008, A2, . Location in patent: Page/Page column 35; 43
[9] Recueil: Journal of the Royal Netherlands Chemical Society, 1981, vol. 100, # 5, p. 204 - 207
[10] Chemistry - A European Journal, 2011, vol. 17, # 51, p. 14380 - 14384
[11] Journal of Medicinal Chemistry, 2010, vol. 53, # 4, p. 1509 - 1518
[12] Patent: WO2008/94846, 2008, A1, . Location in patent: Page/Page column 95
[13] Tetrahedron, 2009, vol. 65, # 20, p. 4025 - 4034
[14] Chemistry - A European Journal, 2009, vol. 15, # 25, p. 6267 - 6278
[15] Monatshefte fuer Chemie, 1952, vol. 83, p. 541
[16] Journal of the American Chemical Society, 1975, vol. 97, p. 5409 - 5417
[17] Journal of Organic Chemistry, 1983, vol. 48, # 13, p. 2141 - 2146
[18] Journal of Organic Chemistry, 1995, vol. 60, # 24, p. 8074 - 8080
[19] Tetrahedron Letters, 1997, vol. 38, # 29, p. 5223 - 5224
[20] Tetrahedron Letters, 1998, vol. 39, # 8, p. 917 - 918
[21] Heterocycles, 1998, vol. 47, # 2, p. 765 - 780
[22] Journal of Organic Chemistry, 1999, vol. 64, # 26, p. 9450 - 9458
[23] Organic Letters, 2000, vol. 2, # 6, p. 775 - 777
[24] Journal of Chemical Research, 2004, # 9, p. 605 - 607
[25] Tetrahedron Letters, 2005, vol. 46, # 22, p. 3801 - 3805
[26] Tetrahedron Letters, 2005, vol. 46, # 41, p. 7069 - 7072
[27] Organic Letters, 2005, vol. 7, # 6, p. 1059 - 1062
[28] Tetrahedron Asymmetry, 2006, vol. 17, # 13, p. 2028 - 2033
[29] Journal of the American Chemical Society, 2006, vol. 128, # 12, p. 4023 - 4034
[30] Tetrahedron, 2006, vol. 62, # 29, p. 6782 - 6791
[31] Tetrahedron Letters, 2007, vol. 48, # 14, p. 2471 - 2475
[32] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, # 8, p. 1673 - 1676
[33] Synthetic Communications, 1991, vol. 21, # 1, p. 1 - 9
[34] Synthesis, 2007, # 10, p. 1528 - 1534
[35] Tetrahedron Letters, 2007, vol. 48, # 50, p. 8914 - 8917
[36] Bulletin des Societes Chimiques Belges, 1985, vol. 94, # 8, p. 605 - 614
[37] Journal of the American Chemical Society, 1952, vol. 74, p. 1096
[38] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1973, p. 2094 - 2097
[39] Journal of medicinal chemistry, 1966, vol. 9, # 6, p. 911 - 920
[40] Patent: WO2004/22522, 2004, A1, . Location in patent: Page/Page column 8
[41] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 3, p. 926 - 929
[42] Organic Letters, 2010, vol. 12, # 3, p. 420 - 423
[43] Monatshefte fur Chemie, 2010, vol. 141, # 2, p. 177 - 198
[44] Heterocycles, 2009, vol. 77, # 2, p. 865 - 872
[45] Tetrahedron Letters, 2011, vol. 52, # 22, p. 2873 - 2875
[46] Angewandte Chemie - International Edition, 2012, vol. 51, # 31, p. 7825 - 7829
[47] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6305 - 6312,8
[48] Tetrahedron, 2012, vol. 68, # 51, p. 10470 - 10475,6
[49] ACS Medicinal Chemistry Letters, 2013, vol. 4, # 7, p. 666 - 670
[50] Journal of Organometallic Chemistry, 2013, vol. 729, p. 46 - 52
[51] Journal of Molecular Catalysis A: Chemical, 2013, vol. 379, p. 225 - 233
[52] Chirality, 2013, vol. 25, # 2, p. 119 - 125
[53] European Journal of Organic Chemistry, 2013, # 23, p. 5036 - 5040
[54] Organic and Biomolecular Chemistry, 2013, vol. 11, # 46, p. 8092 - 8102
[55] Inorganica Chimica Acta, 2014, vol. 409, # PART B, p. 244 - 253
[56] Chemico-Biological Interactions, 2014, vol. 217, p. 41 - 48
[57] European Journal of Organic Chemistry, 2015, vol. 2015, # 6, p. 1325 - 1332
[58] Beilstein Journal of Organic Chemistry, 2015, vol. 11, p. 524 - 529
[59] Journal of Organic Chemistry, 2015, vol. 80, # 20, p. 9926 - 9941
[60] Journal of Agricultural and Food Chemistry, 2016, vol. 64, # 46, p. 8927 - 8934
[61] Chemistry - A European Journal, 2016, vol. 22, # 43, p. 15529 - 15535
[62] Phosphorus, Sulfur and Silicon and the Related Elements, 2017, vol. 192, # 5, p. 555 - 559
  • 4
  • [ 157985-15-4 ]
  • [ 7533-40-6 ]
Reference: [1] Heterocycles, 1994, vol. 37, # 3, p. 1469 - 1472
[2] Tetrahedron, 2000, vol. 56, # 2, p. 233 - 248
  • 5
  • [ 7517-19-3 ]
  • [ 7533-40-6 ]
  • [ 16679-66-6 ]
YieldReaction ConditionsOperation in experiment
59.3 %Chromat.
Stage #1: With sodium carbonate In water
Stage #2: With CuZn0.3Mg0.1AlO(x); hydrogen In ethanol at 80℃; for 10 h; Autoclave
General procedure: The activity of catalyst for hydrogenation of R-phenylglycinemethyl ester was tested in a 0.5 L stainless steelautoclave under stirring at a speed of 500rpm. After 1g catalyst (20–40 mesh) was put in the reactor, the reactorwas swept with H2 five times to flush out air. Thenthe catalyst was reduced at 1MPa H2and 250 °C for 4h. After the autoclave was cooled in H2atmosphere to roomtemperature, 1.5g R-phenylglycine methyl esters (R-p-m)diluted in 150 mL ethanol was added (R-p-m/Cat = 1.5,wt.). The typical reaction conditions were at 5 MPa of H2 and 80 °C for 10 h. After the reaction was ended, theautoclave was cooled in H2atmosphere to room temperature.Then solid catalyst was separated by centrifugation.The product was purified by column chromatography on silica gel with ethyl acetate/methanol (3/2, v/v) as the eluent.Thus we obtained the light yellow powder product byrotary evaporation. Reactants and products were analyzedby High Performance Liquid Chromatograph (HPLC, Agilent1260 Infinity) equipped with an ultraviolet detector anda column (Eclipse XDB-C18, 150 × 4.6mm, 5mm particlesize), then the conversion of R-phenylglycine methyl ester(X), yield (Y) and chemoselectivity to R-phenylglycinol (S)were calculated [18, 19], in which the yield is the LC yield.And the ee value of products was determined by HPLCequipped with an ultraviolet detector (wavelength 258nm)and a chiral column (CHIRALPAK AY-H, 250 × 4.6mm,5m particle size) [19].
Reference: [1] Catalysis Letters, 2017, vol. 147, # 8, p. 2160 - 2166
  • 6
  • [ 2743-60-4 ]
  • [ 7533-40-6 ]
Reference: [1] Helvetica Chimica Acta, 1948, vol. 31, p. 1617,1623
[2] Journal of Biological Chemistry, 1940, vol. 134, p. 155
[3] Journal of the American Chemical Society, 1940, vol. 62, p. 677
[4] Journal of the American Chemical Society, 1952, vol. 74, p. 1096
[5] Helvetica Chimica Acta, 1961, vol. 44, p. 206 - 212
[6] Journal of medicinal chemistry, 1966, vol. 9, # 6, p. 911 - 920
[7] Journal of the Chemical Society, 1964, p. 3965 - 3972
  • 7
  • [ 2743-40-0 ]
  • [ 7533-40-6 ]
Reference: [1] Agricultural and Biological Chemistry, 1980, vol. 44, # 7, p. 1489 - 1498
[2] Tetrahedron Letters, 1977, p. 3527 - 3528
[3] Patent: US4885292, 1989, A,
  • 8
  • [ 6216-61-1 ]
  • [ 7533-40-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 13, p. 3038 - 3041
[2] Journal of Medicinal Chemistry, 1998, vol. 41, # 22, p. 4301 - 4308
  • 9
  • [ 157985-05-2 ]
  • [ 7533-40-6 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 2, p. 233 - 248
[2] Heterocycles, 1994, vol. 37, # 3, p. 1469 - 1472
  • 10
  • [ 261963-26-2 ]
  • [ 7533-40-6 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 2, p. 233 - 248
[2] Heterocycles, 1994, vol. 37, # 3, p. 1469 - 1472
  • 11
  • [ 61-90-5 ]
  • [ 7533-40-6 ]
Reference: [1] Synthesis, 2012, vol. 44, # 7, p. 1057 - 1062
  • 12
  • [ 98559-87-6 ]
  • [ 7533-40-6 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 2, p. 233 - 248
  • 13
  • [ 4113-63-7 ]
  • [ 7533-40-6 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 2, p. 233 - 248
  • 14
  • [ 2018-66-8 ]
  • [ 7533-40-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 13, p. 3038 - 3041
  • 15
  • [ 2026-48-4 ]
  • [ 7533-40-6 ]
Reference: [1] New Journal of Chemistry, 2009, vol. 33, # 1, p. 181 - 185
  • 16
  • [ 7533-40-6 ]
  • [ 28862-79-5 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 535 - 540
  • 17
  • [ 7533-40-6 ]
  • [ 24424-99-5 ]
  • [ 106930-51-2 ]
Reference: [1] Patent: US5436257, 1995, A,
[2] Patent: WO2007/22371, 2007, A2, . Location in patent: Page/Page column 39
[3] Tetrahedron Letters, 2011, vol. 52, # 27, p. 3496 - 3498
[4] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6305 - 6312,8
[5] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 7, p. 787 - 792
  • 18
  • [ 7533-40-6 ]
  • [ 28920-43-6 ]
  • [ 139551-83-0 ]
YieldReaction ConditionsOperation in experiment
87% at 20℃; for 0.0333333 h; Sonication; Irradiation; Green chemistry General procedure: Amine (1 mmol) and Fmoc-Cl (1.1 mmol) were placed in a glass tube under neat conditions and were sonicated for a suitable time (as indicated in Tables 1, 2 and 3). All reactions were performed in a water bath at room temperature. After completion of the reaction (as indicated by TLC), 5 cm3 of diethyl ether was added to the mixture. The N-Fmoc derivatives were crystallized and were obtained in good to excellent yields. Purification of the product was accomplished by recrystallization from diethyl ether.
Reference: [1] Journal of the Brazilian Chemical Society, 2016, vol. 27, # 3, p. 546 - 550
[2] Journal of the American Chemical Society, 2006, vol. 128, # 12, p. 4023 - 4034
  • 19
  • [ 7533-40-6 ]
  • [ 82911-69-1 ]
  • [ 139551-83-0 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 45, p. 12337 - 12350
[2] Tetrahedron Letters, 1995, vol. 36, # 1, p. 167 - 168
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 7533-40-6 ]

Amino Acid Derivatives

Chemical Structure| 24629-25-2

[ 24629-25-2 ]

(2S,3S)-2-Amino-3-methylpentan-1-ol

Similarity: 0.95

Chemical Structure| 22724-81-8

[ 22724-81-8 ]

(S)-2-Aminopentan-1-ol

Similarity: 0.90

Chemical Structure| 2026-48-4

[ 2026-48-4 ]

(S)-2-Amino-3-methylbutan-1-ol

Similarity: 0.86

Chemical Structure| 4276-09-9

[ 4276-09-9 ]

D-Valinol

Similarity: 0.86

Chemical Structure| 16369-05-4

[ 16369-05-4 ]

2-Amino-3-methylbutan-1-ol

Similarity: 0.86